DOCSLIB.ORG

Tweet About the Annual Meeting: Use #ASBMB2010

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Tweet About the Annual Meeting: Use #ASBMB2010 TweeT abouT The annual meeTing: use #ASBMB2010 April 2010 American Society for Biochemistry and Molecular Biology Abstract Submission and Registration Opening Soon! September 30 – October 4, 2010 Transcriptional Regulation by Chromatin and RNA Polymerase II Granlibakken Resort, Tahoe City, CA Organizer: Ali Shilatifard Stowers Institute for Medical Research October 14 – October 17, 2010 Biochemistry and Cell Biology Of ESCRTs in Health and Disease Snowbird Resort, Snowbird, UT Organizer: James Hurley National Institute of Diabetes and Digestive and Kidney Diseases Phyllis Hanson Washington University School of Medicine October 21 – October 24, 2010 Detection and Physiological Evaluation Granlibakken Resort, Tahoe City, CA Organizer: Katalin Medzihradszky University of California, San Francisco Gerald Hart Johns Hopkins University School of Medicine October 28 – October 31, 2010 Secretory and Endocytic Pathways Granlibakken Resort, Tahoe City, CA Organizer: Stanford University School of Medicine Vivek Malhotra Center for Genomic Regulation, Barcelona, Spain www.asbmb.org/meetings contents April 2010 On the cover: Read about the work of Jorge Cham, society news our cover artist, 2 Letters to the Editor and other science cartoons. 16 4 President’s Message Cover imAge reprinted with permission from Jorge ChAm. 6 News from the Hill 9 Washington Update 10 ASBMB Journal Innovations 11 ASBMB Announces Diversity in Science Award 12 Retrospective: Philip Siekevitz (1918 – 2009) Social Media at the Annual Meeting. 13 Retrospective: 23 Marshall Nirenberg (1927 – 2010) 14 Member Spotlight feature stories 16 The Graduate Student Experience, In Four Panels 2010 annual meeting 20 Getting the Most Out of the Annual Meeting 22 Back by Popular Demand: The Annual Meeting Compendia in every issue 23 Sci.comm The ASBMB 2010 special symposia lineup. 28 24 Education 27 Minority Affairs 28 Meetings 32 BioBits asbmb today online 34 Career Insights In this month’s podcast, you can hear JBC Associate Editor Dale Benos talk about a new 36 Lipid News thematic minireview series he is coordinating on the biochemistry of hypertension. To hear this and other podcasts, go to www.asbmb.org/Interactive.aspx. April 2010 ASBMB Today 1 letters to the editor A monthly publication of the American society for harm— ironically one of the main rea- Biochemistry and molecular Biology Advice and sons he was chosen to head the ACMD. Officers According to the now ex-chief of the Gregory A. Petsko President Dissent Suzanne R. Pfeffer President-Elect ACMD, he got approval of both the Mark A. Lemmon Secretary lecture slides and text from the relevant Merle S. Olson Treasurer Dear Editor, I would start by saying that “El government department (http://bit.ly/ Council Members Dafna Bar-Sagi Ruma V. Banerjee Presidente’s” messages are one of the cGo8UV). The lecture was in the public Benjamin F. Cravatt Joan A. Steitz reasons I browse ASBMB Today. I not domain in July 2009, and the sacking Thomas E. Smith Ann M. Stock James A. Wells Adrian Whitty only find myself generally in agree- did not occur until it was published as a briefing pamphlet by the organizers Ex-Officio Members ment with the opinions expressed in Ellis Bell his messages on various subjects, but I at the CCJS in October 2009 (which, I Chair, education and professional development Committee also enjoy his refreshing outspokenness guess, if it had not been at the center Joan W. Conaway on controversial issues (such as on the of the sacking, would have been read Chair, meetings Committee John D. Scott financial crisis and big pharma, ASBMB by fewer readers than those of ASBMB Chair, membership Committee Today, May 2009) and his tendency to Today). Craig E. Cameron Chair, minority Affairs Committee tell the truth to power (i.e., his critiques The transcript (http://bit.ly/cfWVoD), Laurie S. Kaguni of the former U.S. administration). I which is not bedtime reading, is evi- 2010 Annual meeting program Coordinator William C. Merrick was, therefore, surprised to see coy- dently meant for connoisseurs and the Chair, public Affairs Advisory Committee ness and a nod about the actualité highly referenced. It appears that the Toni M. Antalis Chair, publications Committee politique from the United Kingdom— assessment that Nutt had delved into Herbert Tabor namely the dismissal of the chief of policy and politics rather than sticking editor, JBC Ralph A. Bradshaw the Advisory Council on the Misuse of to science (a judgment both the home A. L. Burlingame Drugs (ASBMB Today, Dec. 2009). This secretary and Petsko seem to arrive at) Co-editors, MCP Edward A. Dennis particular case, in my view, is an issue is the result of the last paragraph of the Joseph L. Witztum of academic freedom. It ought to be lecture: Co-editors, JLR an important freedom, particularly for “Another key question we have to ASBMB Today Editorial Advisory Board Alex Toker scientists who advise politicians, and, in address as a society is whether our Chair my view, distinguishes them from being attitude to drugs is driven because of Greg P. Bertenshaw Craig E. Cameron A. Stephen Dahms Irwin Fridovich perceived as politicians. their harms or are we engaging in a Jonathan Gitlin Richard W. Hanson The purpose of my letter is not to moral debate? One thing this govern- Elizabeth A. Komives Bettie Sue Masters ment has done extremely well in the Luke A. O’Neill Duanqing Pei defend David Nutt, who, I am sure, is Carol C. Shoulders Robert D. Wells more than capable of his own defense. last ten years is to cut away much of the ASBMB Today I also do not wish to speculate on moral argument about drug treatments. Nicole Kresge Editor why the home secretary of the United They have moved in the direction of [email protected] Kingdom government decided Nutt was improving access to harm-reduction Nick Zagorski Science Writer [email protected] surplus to requirement. I am writing treatments, an approach that, I think, is Nancy J. Rodnan Director of Publications because I disagree with the implica- wholly endorsed by the scientific com- [email protected] tion of the president’s message that munity and by the medical profession. Barbara Gordon Executive Director [email protected] somehow there are clear dividing lines For reasons that are not clear, the same Magazine design & production: Amy Phifer between scientific assessment and pol- evidence-based change has not hap- icy advice, particularly when the public pened in relation to the classification for information on advertising, contact Capitol media solutions at 800-517-0610 perception of risk and risk assessment of drugs of misuse. I think it should or [email protected] are under consideration. happen, because, while I’m not a moral The reasons given for sacking Nutt philosopher, it seems to me difficult to are in the public domain: publication of defend a moral argument in relation an academic lecture given to the Center to drugs if you don’t apply it to other www.asbmb.org for Crime and Justice Studies at Kings equally harmful activities.” College, London, in July 2009. Nutt In the context of a lecture that pur- gave the lecture in his capacity as an ports to identify and compare various expert in the area of drug misuse and risks and harm (including devising a 2 ASBMB Today April 2010 letters to the editor drugs harm ranking), and the audience scientific and religious thought. districts, to give them the information to which it was delivered, I leave it to I feel that we should be doing they need to make science current and the readers of ASBMB Today to decide something to engage the public, to let relevant to their students. I believe that if the offending paragraph is reason them know about the excitement and it is incumbent upon us to engage the enough to justify having an “agenda,” fascination of science. If every college public in this dialogue. In our experi- as Petsko suggests. The debate about and university in the country were to ence, the faculty members are elated to risks afflicting modern existence is develop a lecture series focused on engage in this sort of outreach, and, in fraught with irrationality and politics. science for the public, it would advance our neck of the world, at least, we are It could do without sane, rational men our cause enormously. having great success. advocating for more of its politiciza- Here, in inland Southern Califor- Thomas O. Baldwin tion. I would finish by quoting from nia, where I landed 18 months ago, Dean, College of Natural and the condemned man’s lecture: “I think religious conservatives make up a Agricultural Sciences we need to improve the general under- significant percentage of the popula- University of California, Riverside standing of relative harms. I think we tion. Shortly after arriving, I chal- need to educate people about drug lenged our faculty members to develop harms in relation to the harms of other a five-lecture series on the science Erratum: activities in life, so that it is possible for of evolution. The faculty members The final paragraph in the March them to make sensible decisions about initially were concerned that the public Lipid News article “The Unmask- relative harms.” would either torch the campus or just ing of Plasmalogens: Chlorinated Aamir Ahmed not show up. They wanted to hold the Lipids” contains some factual University College London lectures in a small classroom since they errors. The corrected paragraph were sure that no more than 20 people should read: would attend. I insisted that we use the “In the future, we should university theater, which seats about Engaging consider the significance of the 500. As it turned out, the series was accumulation of chlorinated lipids the public standing-room-only— people literally filled the aisles— at all five lectures.
Load more

Recommended publications
  • Download Issue
    Cell Circuitry || Science Teaches English || The Chicken Genome Is Hot || Magnets in Medicine SEPTEMBER 2002 www.hhmi.org/bulletin Leading Doublea Life It’s a stretch, but doctors who work bench to bedside say they wouldn’t do it any other way. FEATURES 14 On Human Terms 24 The Evolutionary War A small—some say too small—group of Efforts to undermine evolution education have physician-scientists believes the best science evolved into a 21st-century marketing cam- requires patient contact. paign that relies on legal acumen, manipulation By Marlene Cimons of scientific literature and grassroots tactics. 20 Engineering the Cell By Trisha Gura Adam Arkin sees the cell as a mechanical system. He hopes to transform molecular 28 Call of the Wild biology into a kind of cellular engineering Could quirky, new animal models help scien- and in the process, learn how to move cells tists learn how to regenerate human limbs or from sickness to health. avert the debilitating effects of a stroke? By M. Mitchell Waldrop By Kathryn Brown 24 In front of a crowd of 1,500, Ohio’s Board of Education heard testimony on whether students should learn about intelligent design in science class. DEPARTMENTS 2 NOTA BENE 33 PERSPECTIVE ulletin Intelligent Design Is a Cop-Out 4 LETTERS September 2002 || Volume 15 Number 3 NEWS AND NOTES HHMI TRUSTEES PRESIDENT’S LETTER 5 JAMES A. BAKER, III, ESQ. 34 Senior Partner, Baker & Botts A Creative Influence In from the Fields ALEXANDER G. BEARN, M.D. Executive Officer, American Philosophical Society 35 Lost on the Tip of the Tongue Adjunct Professor, The Rockefeller University UP FRONT Professor Emeritus of Medicine, Cornell University Medical College 36 Biology by Numbers FRANK WILLIAM GAY 6 Follow the Songbird Former President and Chief Executive Officer, SUMMA Corporation JAMES H.
    [Show full text]
  • EMBC Annual Report 2007
    EMBO | EMBC annual report 2007 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION | EUROPEAN MOLECULAR BIOLOGY CONFERENCE EMBO | EMBC table of contents introduction preface by Hermann Bujard, EMBO 4 preface by Tim Hunt and Christiane Nüsslein-Volhard, EMBO Council 6 preface by Marja Makarow and Isabella Beretta, EMBC 7 past & present timeline 10 brief history 11 EMBO | EMBC | EMBL aims 12 EMBO actions 2007 15 EMBC actions 2007 17 EMBO & EMBC programmes and activities fellowship programme 20 courses & workshops programme 21 young investigator programme 22 installation grants 23 science & society programme 24 electronic information programme 25 EMBO activities The EMBO Journal 28 EMBO reports 29 Molecular Systems Biology 30 journal subject categories 31 national science reviews 32 women in science 33 gold medal 34 award for communication in the life sciences 35 plenary lectures 36 communications 37 European Life Sciences Forum (ELSF) 38 ➔ 2 table of contents appendix EMBC delegates and advisers 42 EMBC scale of contributions 49 EMBO council members 2007 50 EMBO committee members & auditors 2007 51 EMBO council members 2008 52 EMBO committee members & auditors 2008 53 EMBO members elected in 2007 54 advisory editorial boards & senior editors 2007 64 long-term fellowship awards 2007 66 long-term fellowships: statistics 82 long-term fellowships 2007: geographical distribution 84 short-term fellowship awards 2007 86 short-term fellowships: statistics 104 short-term fellowships 2007: geographical distribution 106 young investigators 2007 108 installation
    [Show full text]
  • 2019 Annual Report
    BECKMAN CENTER 279 Campus Drive West Stanford, CA 94305 650.723.8423 Stanford University | Beckman Center 2019 Annual Report Annual 2019 | Beckman Center University Stanford beckman.stanford.edu 2019 ANNUAL REPORT ARNOLD AND MABEL BECKMAN CENTER FOR MOLECULAR AND GENETIC MEDICINE 30 Years of Innovation, Discovery, and Leadership in the Life Sciences CREDITS: Cover Design: Neil Murphy, Ghostdog Design Graphic Design: Jack Lem, AlphaGraphics Mountain View Photography: Justin Lewis Beckman Center Director Photo: Christine Baker, Lotus Pod Designs MESSAGE FROM THE DIRECTOR Dear Friends and Trustees, It has been 30 years since the Beckman Center for Molecular and Genetic Medicine at Stanford University School of Medicine opened its doors in 1989. The number of translational scientific discoveries and technological innovations derived from the center’s research labs over the course of the past three decades has been remarkable. Equally remarkable have been the number of scientific awards and honors, including Nobel prizes, received by Beckman faculty and the number of young scientists mentored by Beckman faculty who have gone on to prominent positions in academia, bio-technology and related fields. This year we include several featured articles on these accomplishments. In the field of translational medicine, these discoveries range from the causes of skin, bladder and other cancers, to the identification of human stem cells, from the design of new antifungals and antibiotics to the molecular underpinnings of autism, and from opioids for pain
    [Show full text]
  • April 2007 ASCB Newsletter
    ASCB A P R I L 2 0 0 7 NEWSLETTER VOLUME 30, NUMBER 4 MBC: Eliminate Hogan, Meyerowitz Shapiro to the Printed Journal? Run for ASCB President Present Page 4 Brigid Hogan of Duke Medical Center and Elliot Meyerowitz of the California Institute Porter of Technology/HHMI are running for ASCB 47th ASCB President. The elected candidate will serve on the Society’s Executive Committee Lecture Annual Meeting as President-Elect in 2008 and as ASCB Lucy Shapiro President in 2009. of Stanford Program Brigid Hogan Duke Medical Eight candidates will compete for four three- University Page 8 Center year terms as Councilor. All those elected start School of service on January 1, 2008. Medicine has An email with a link to the Society’s been named NIH Director electronic ballot and candidate biographies Lucy Shapiro by ASCB Criticizes Bush will be sent to regular, postdoctoral, and President emeritus members. Bruce M. Stem Cell Policy The election closes on June 30. Results will Alberts to give the 26th Annual be announced in the July issue of the ASCB Keith R. Porter Lecture. Page 13 Elliot Meyerowitz Newsletter. Her lecture, “Spatial and California 2004 ASCB President Harvey F. Lodish Topological Components of Institute of of the Whitehead Institute for Biomedical Bacterial Cell Cycle Regulatory Inside Technology/ Circuitry,” will be presented HHMI Research served as Nominating Committee Chair; also serving on the Committee were during the 47th ASCB Annual Gary G. Borisy, Joanne Chory, Anthony P. Meeting in Washington, DC, President’s Column 2 Mahowald, Suzanne R. Pfeffer, Laura J. Robles, Pamela A.
    [Show full text]
  • Pnas11052ackreviewers 5098..5136
    Acknowledgment of Reviewers, 2013 The PNAS editors would like to thank all the individuals who dedicated their considerable time and expertise to the journal by serving as reviewers in 2013. Their generous contribution is deeply appreciated. A Harald Ade Takaaki Akaike Heather Allen Ariel Amir Scott Aaronson Karen Adelman Katerina Akassoglou Icarus Allen Ido Amit Stuart Aaronson Zach Adelman Arne Akbar John Allen Angelika Amon Adam Abate Pia Adelroth Erol Akcay Karen Allen Hubert Amrein Abul Abbas David Adelson Mark Akeson Lisa Allen Serge Amselem Tarek Abbas Alan Aderem Anna Akhmanova Nicola Allen Derk Amsen Jonathan Abbatt Neil Adger Shizuo Akira Paul Allen Esther Amstad Shahal Abbo Noam Adir Ramesh Akkina Philip Allen I. Jonathan Amster Patrick Abbot Jess Adkins Klaus Aktories Toby Allen Ronald Amundson Albert Abbott Elizabeth Adkins-Regan Muhammad Alam James Allison Katrin Amunts Geoff Abbott Roee Admon Eric Alani Mead Allison Myron Amusia Larry Abbott Walter Adriani Pietro Alano Isabel Allona Gynheung An Nicholas Abbott Ruedi Aebersold Cedric Alaux Robin Allshire Zhiqiang An Rasha Abdel Rahman Ueli Aebi Maher Alayyoubi Abigail Allwood Ranjit Anand Zalfa Abdel-Malek Martin Aeschlimann Richard Alba Julian Allwood Beau Ances Minori Abe Ruslan Afasizhev Salim Al-Babili Eric Alm David Andelman Kathryn Abel Markus Affolter Salvatore Albani Benjamin Alman John Anderies Asa Abeliovich Dritan Agalliu Silas Alben Steven Almo Gregor Anderluh John Aber David Agard Mark Alber Douglas Almond Bogi Andersen Geoff Abers Aneel Aggarwal Reka Albert Genevieve Almouzni George Andersen Rohan Abeyaratne Anurag Agrawal R. Craig Albertson Noga Alon Gregers Andersen Susan Abmayr Arun Agrawal Roy Alcalay Uri Alon Ken Andersen Ehab Abouheif Paul Agris Antonio Alcami Claudio Alonso Olaf Andersen Soman Abraham H.
    [Show full text]
  • Research Organizations and Major Discoveries in Twentieth-Century Science: a Case Study of Excellence in Biomedical Research
    A Service of Leibniz-Informationszentrum econstor Wirtschaft Leibniz Information Centre Make Your Publications Visible. zbw for Economics Hollingsworth, Joseph Rogers Working Paper Research organizations and major discoveries in twentieth-century science: A case study of excellence in biomedical research WZB Discussion Paper, No. P 02-003 Provided in Cooperation with: WZB Berlin Social Science Center Suggested Citation: Hollingsworth, Joseph Rogers (2002) : Research organizations and major discoveries in twentieth-century science: A case study of excellence in biomedical research, WZB Discussion Paper, No. P 02-003, Wissenschaftszentrum Berlin für Sozialforschung (WZB), Berlin This Version is available at: http://hdl.handle.net/10419/50229 Standard-Nutzungsbedingungen: Terms of use: Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Documents in EconStor may be saved and copied for your Zwecken und zum Privatgebrauch gespeichert und kopiert werden. personal and scholarly purposes. Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle You are not to copy documents for public or commercial Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich purposes, to exhibit the documents publicly, to make them machen, vertreiben oder anderweitig nutzen. publicly available on the internet, or to distribute or otherwise use the documents in public. Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, If the documents have been made available under an Open gelten abweichend von diesen Nutzungsbedingungen die in der dort Content Licence (especially Creative Commons Licences), you genannten Lizenz gewährten Nutzungsrechte. may exercise further usage rights as specified in the indicated licence. www.econstor.eu P 02 – 003 RESEARCH ORGANIZATIONS AND MAJOR DISCOVERIES IN TWENTIETH-CENTURY SCIENCE: A CASE STUDY OF EXCELLENCE IN BIOMEDICAL RESEARCH J.
    [Show full text]
  • Thank You to Our 2016 Donors
    THANK YOU TO OUR 2016 DONORS Lifetime Giving Society Rush Holt and Celeste M. Rohlfing Roger and Terry Beachy Mary E. Clutter The Lifetime Giving Margaret Lancefield Robert L. Smith Jr. Cynthia M. Beall Morrel H. Cohen Society recognizes Alice S. Huang and Daniel Vapnek Gary and Fay Beauchamp Donald G. Comb individuals who have David Baltimore contributed a cumulative Raymond G. Beausoleil Jeffrey A. Cooper total of $100,000 or more $2,500-$4,999 $25,000- $49,999 Nicholas A. Begovich Jonathan C. Coopersmith during the course of their Anonymous, in memory Kenneth A. Cowin involvement of Myrtle Ray Zeiber, Jerry A. Bell and Vincent D’Aco with AAAS. Benjamin C. Hammett Jill Sharon Sheridon, Mary Ann Stepp William H. Danforth Tucker Hake Alan and Agnes Leshner May R. Berenbaum Peter B. Danzig Kathleen S. Berger Edwin J. Adlerman Lawrence H. Linden Margaret M. Betchart Vincent Davisson Stephen and Janelle Ersen Arseven Fodor David E. Shaw and James Bielenberg David H. de Weese Beth Kobliner Shaw David R. Atkinson Richard M. Forester † Dennis M. Bier Jeffrey S. Dean Drs. Larry and Jan Allison Bigbee Sibyl R. Golden and $10,000- $24,999 Baldwin John and Mary Deane the Golden Family Thomas R. and Johanna Amy Blackwell Helena L. Chum George E. DeBoer Rush Holt and K. Baruch Peter D. Blair Hans G. Dehmelt Margaret Lancefield Jonathan Bellack Rita R. and Jack H. Colwell C. John Blankley Charles W. Dewitt Alan and Agnes Leshner Floyd E. Bloom Troy E. Daniels Carla Blumberg Ruth A. Douglas Lawrence H. Linden Fred A.
    [Show full text]
  • George Emil Palade Ia#I, Romania, 19 Nov
    George Emil Palade Ia#i, Romania, 19 Nov. 1912 - Ia#i, Romania, 8 Oct. 2008 Nomination 2 Dec. 1975 Field Cell Biology Title Professor of Medicine in Residence, Emeritus, and Dean for Scientific Affairs, Emeritus, University of California, San Diego Commemoration – George Emil Palade was born on November 19, 1912, in Jassy, Romania. He studied medicine at the University of Bucharest, graduating in 1940. Already as a student, he became interested in microscopic anatomy and its relation to function and decided early to relinquish clinical medicine for research. After serving in the Romanian army during the Second World War, he moved to the United States in 1946, soon joining the laboratory of Albert Claude at the Rockefeller Institute for Medical Research, where, after Claude’s return to Belgium in 1949, he developed an independent laboratory, first in association with Keith Porter and later, after Porter’s departure in 1961, on his own. He stayed at what had become the Rockefeller University until 1973, when he moved to Yale University. His later years were spent at the University of California, San Diego, where he acted as Dean of Scientific Affairs. He passed away on 7 October 2008, after suffering major health problems, including macular degeneration leading to total blindness, a particularly painful ordeal for a man who had used his eyes all his life in a particularly creative way. He leaves two children from his first marriage with Irina Malaxa: Georgia Palade Van Duzen and Philip Palade. He married Marilyn G. Farquhar, a cell biologist, in 1971, after the death of his first wife.
    [Show full text]
  • Stem Cell Biology
    HIGHLIGHTS AND FUTURE PROSPECTS VASSIE C. WARE, Ph.D. LEHIGH UNIVERSITY MULTIDISCIPLINARY APPROACHES BIOLOGICAL ENGINEERS BIOCHEMISTS MOLECULAR BIOLOGISTS NEUROBIOLOGISTS MICROBIOLOGISTS CHEMISTS CLINICIANS CELL BIOLOGISTS VIROLOGISTS BIOETHICISTS & PHYSICISTS MEDICAL HUMANISTS MECHANICAL ENGINEERS COMPUTER SCIENTISTS PROBLEMS IN BIOSCIENCE Genomics and Genomic Technologies Drug Delivery Ethical and social implications Obesity Cardiovascular Disease Neurological Disease Behavioral disorders Infectious Diseases Stem Cells and Regenerative Medicine Cancer Recent advances: Genomics and Genomic Technologies - understanding microbial genomes for biomedical applications and biofuel/bioremediation applications - drug development prospects - pharmacogenomics Stem Cell Biology - tracking stem cells in the brain to understand neurological disease - understanding disease mechanisms in the laboratory - drug development prospects Ethical Considerations First Bacterial Genome Transplantation Changes One Species To Another (Science, August 2007) Changed one bacterial species, Mycoplasma capricolum into another, Mycoplasma mycoides Large Colony (LC), by replacing one organism’s genome with the other one’s genome. WHY? …“We are committed to this research as we believe that synthetic genomics holds great promise in helping to solve issues like climate change and in developing new sources of energy.” ETHICAL AND SOCIAL CONCERNS? In collaboration with the Center for Strategic & International Studies (CSIS), and the Massachusetts Institute of Technology (MIT),
    [Show full text]
  • Philip Siekevitz 1918-2009
    PHILIP SIEKEVITZ 1918-2009 A Biographical Memoir by DAVID D. SABATINI © 2012 National Academy of Sciences Any opinions expressed in this memoir are those of the author and do not necessarily reflect the views of the National Academy of Sciences. PHILIP SIEKEVITZ February 25, 1918–December 5, 2009 BY DAVID D. SABATINI 1 The text and references in this article originally appeared in the Journal of Cell Biology 189(2010):3-5, and are reprinted here with the journal’s permission. PHILIP SIEKEVITZ, AN EMERITUS PROFESSOR at the Rockefeller University who made pioneering contributions to the development of modern cell biology, passed away on December 5th, 2009. He was a creative and enthusiastic scientist, as well as a great experimentalist who throughout his lifetime transmitted the joy of practicing science and the happiness that comes with the acquisition of new knowledge. He was a man of great integrity, with a thoroughly engaging person- ality and a humility not often found in people of his talent. PHILIP SIEKEVITZ PHILIP Philip Siekevitz’s career proceeded along three phases marked by seminal warfare attacks. Because he was eager to enhance his scientific background, Siekevitz requested a transfer, contributions that opened up new avenues of research. The first phase was which resulted in his deployment as a laboratory techni- in the field of protein synthesis, in which he developed the first in vitro cian to an Air Force Supply Base for the Pacific War in system using defined cell fractions. Then, in collaboration with George San Bernardino, California, where he honed his skills in microscopy and chemical analysis.
    [Show full text]
  • Dr. Lucy Shapiro Is a Professor of Developmental Biology at Stanford School of Medicine Where She Holds the Virginia and RESEARCH with IMPACT D.K
    UNIVERSITY LECTURE SERIES ONE SHEET Save the Date: How does a cell execute the many functions that define a living entity? We discovered that robust chemically and genetically based May 5 at 5:30 p.m. ET, Virtual Program logic circuits control cell cycle progression and cell differentiation. A critical question is how these control systems function in time and space within a tiny bacterial cell with just 4,000 genes. Lecture Title: We have observed strong parallels between these “genetic circuits” and familiar engineering circuits. These expanding insights The Living Cell as an Integrated System are providing unprecedented understanding of the asymmetric cell differentiation process essential to producing the diverse organisms found on the Earth. LUCY SHAPIRO Virginia and D.K. Ludwig Professor of Developmental Biology, Stanford University Developmental Biologist Researcher Educator Recipient of the 2020 Dickson Prize in Science “It’s the most exciting thing in the world to be a scientist, because FROM ARTIST TO SCIENTIST you’re like a detective — and what I do is try to understand what Shapiro’s start in scientific research took an unconventional life is by starting with a very, very simple bacterial cell and path. She describes her career journey from artist to scientist understanding the genetic circuitry that control a living thing.” in this profile fromThe Scientist. Her success in the field of — Lucy Shapiro developmental biology is a reminder that an interdisciplinary approach to problem-solving is fundamental to innovation. Dr. Lucy Shapiro is a professor of developmental biology at Stanford School of Medicine where she holds the Virginia and RESEARCH WITH IMPACT D.K.
    [Show full text]
  • The First Version of the Signal Hypothesis (1971) Proposed the Presence of a Signal Sequence (X) in the Nascent Polypeptide Chain
    The first version of the signal hypothesis (1971) proposed the presence of a signal sequence (X) in the nascent polypeptide chain. This sequence was predicted to be recog- nized by a ªbinding factorº that mediates binding to the ER membrane. The three-dimensional reconstruction of the ribosome ± Sec61 complex (1997) reveals the alignment of the tunnel in the large ribosomal subunit (blue) and the protein-conducting channel of Sec61 (red). 86 WILEY-VCH-Verlag GmbH, D-69451 Weinheim, 2000 1439-4227/00/01/02 $ 17.50+.50/0 CHEMBIOCHEM 2000,1,86±102 Protein Targeting (Nobel Lecture)** Günter Blobel*[a] KEYWORDS: membranes ´ Nobel lecture ´ proteins ´ protein transport Prologue I began research in the sixties, first as a graduate student in the laboratory of Van R. Potter (Figure 1) at the McArdle Institute for Cancer Research of the University of Wisconsin in Madison. I continued as a postdoctoral fellow in the laboratory of George E. Palade (Figure 2) at The Rockefeller Uni- versity in New York City. At that time, the intracellular pathway of secretory pro- teins, from their synthesis to their extru- sion from the cell, the so-called ªsecre- tory pathwayº, had already been worked out by George Palade and his co-workers, primarily Philip Siekevitz, Jim Jamieson, and Lucien Caro (for review see the 1974 Nobel lecture by George Palade[1] ). Using Figure 3. The secretory pathway. Secretory proteins (indicated in red) are pulse ± chase labeling with radioactive synthesized on ribosomes bound to the endoplasmic reticulum (ER). They are then amino acids in tissue slices in conjunction transported via vesicular carriers through the Golgi complex and are finally exocytosed.
    [Show full text]